As mentioned, the molecular potency of a BoNT?A product is described as the entire number of active (ie, able to binding) 150 kDa neurotoxin molecules current in the injected Alternative.Success: Botulax showed non-inferior efficacy and period to comparator drug. No really serious adverse drug response.Publisher’s Note: MDPI stays neutral with